Genomic Biopharma Inc. is a pharmaceutical research and development firm that is constructing a portfolio of drug initiatives focused on bringing treatments and remedies for infectious and rare diseases to the market. The company's pipeline is informed by insights from Dante Genomics' exclusive repository of complete genetic codes. Genomic Biopharma's primary technology, the GBI AI, utilizes predictive algorithms and genomic data analysis to facilitate the discovery of innovative RNA-based therapies.
Genomic Biopharma
Headquarters
Italy